Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma

J. M. Connors, W. Jurczak, D. J. Straus, S. M. Ansell, W. S. Kim, A. Gallamini, A. Younes, S. Alekseev, A. Illés, M. Picardi, E. Lech-Maranda, Y. Oki, T. Feldman, P. Smolewski, K. J. Savage, N. L. Bartlett, J. Walewski, R. Chen, R. Ramchandren, P. L. ZinzaniD. Cunningham, A. Rosta, N. C. Josephson, E. Song, J. Sachs, R. Liu, H. A. Jolin, D. Huebner, J. Radford

Research output: Contribution to journalArticlepeer-review

284 Scopus citations

Fingerprint

Dive into the research topics of 'Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences